Conference abstractPublished 14 Jul 2014
Engineering controlled release of therapeutics and comfort agents from novel therapeutic contact lenses
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
I t is an exciting time within the field of ophthalmic drug administration, with new methods of delivery showing tremendous promise. The ?go to? products are topical eye drops, which are grossly inefficient delivery vehicles that hold 90% of the ocular pharmaceutics market. With a market valued at ~$15 billion and growing at an 8-10% compound annual growth rate, there is a substantial opportunity for the commercialization of new products that deliver therapeutics more effectively and efficiently to the eye. The creation of enhanced ocular delivery systems has tremendous promise to profoundly impact ocular health via improved treatment options, which will greatly improve quality of life. This presentation will involve a discussion of the challenges and opportunities associated with ocular delivery and one of the most recent novel drug delivery materials, therapeutic contact lenses. Within my research group, we have created a platform technology and a number of novel contact lenses with controlled transport of various therapeutics that can deliver constant amounts of medication to the eye for the duration of lens wear from days to weeks. In comparison, topical eye drops were ~100 times less effective when tested in vivo. Strict control of release is accomplished by engineering the architectural design of biomaterials at the molecular level. Characterization analysis of the network structure of the network in terms of molecular weight between crosslinking points, mesh size, and diffusion studies provides an aid to optimizing the design and begins to answer fundamental questions on the nature of the release control and extended delivery on the chain level. Our research also includes more comfortable and healthy contact lenses, by the controlled release of wettability/comfort agents, which is also one of the most important challenges within the lens industry.
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Mark E. Byrne”
